Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DOUBLE-BOLUS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 26 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Benenati, J; Shlansky-Goldberg, R; Meglin, A; Seidl, E
      Thrombolytic and antiplatelet therapy in peripheral vascular disease with use of reteplase and/or abciximab - The SCVIR Consultants' Conference; May 22, 2000; Orlando, FL

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    2. Marder, VJ
      Thrombolytic therapy: 2001

      BLOOD REVIEWS
    3. Sinnaeve, P; Van de Werf, F
      Thrombolytic therapy - State of the art

      THROMBOSIS RESEARCH
    4. Armstrong, PW; Collen, D
      Fibrinolysis for acute myocardial infarction - Current status and new horizons for pharmacological reperfusion, Part 1

      CIRCULATION
    5. Collen, D; Lijnen, HR
      Recent developments in thrombolytic therapy

      FIBRINOLYSIS & PROTEOLYSIS
    6. Modi, NB; Fox, NL; Clow, FW; Tanswell, P; Cannon, CP; Van de Werf, F; Braunwald, E
      Pharmacokinetics and pharmacodynamics of tenecteplase: Results from a phase II study in patients with acute myocardial infarction

      JOURNAL OF CLINICAL PHARMACOLOGY
    7. Verstraete, M
      Third-generation thrombolytic drugs

      AMERICAN JOURNAL OF MEDICINE
    8. Breuer, M; Schutz, A; Gansera, B; Eichinger, W; Weingartner, J; Kemkes, B
      Intraoperative local fibrinolysis as emergency therapy after early coronary artery bypass thrombosis

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    9. Martin, U; Kaufmann, B; Neugebauer, G
      Current clinical use of reteplase for thrombolysis - A pharmacokinetic-pharmacodynamic perspective

      CLINICAL PHARMACOKINETICS
    10. EPPLER S; SENN T; GILKERSON E; MODI NB
      PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR FOLLOWING INTRAVENOUS ADMINISTRATION IN RABBITS - A COMPARISON OF 3 DOSING REGIMENS

      Biopharmaceutics & drug disposition
    11. AYLWARD P
      CAN WE IMPROVE ON FRONT-LOADED ALTEPLASE (R-TPA)

      Australian and New Zealand Journal of Medicine
    12. BODE C; PETER K; NORDT TK; RUEF J; SMALLING RW; KUBLER W
      PHARMACOLOGY AND CLINICAL EFFICACY OF RETEPLASE

      Fibrinolysis & proteolysis
    13. SMALLING RW
      A FRESH LOOK AT THE MOLECULAR PHARMACOLOGY OF PLASMINOGEN ACTIVATORS - FROM THEORY TO TEST-TUBE TO CLINICAL OUTCOMES

      American journal of health-system pharmacy
    14. SMALLING RW
      PHARMACOLOGICAL AND CLINICAL IMPACT OF THE UNIQUE MOLECULAR-STRUCTUREOF A NEW PLASMINOGEN-ACTIVATOR

      European heart journal
    15. BODE C; PETER K; MOSER M; SMALLING RW; WEAVER WD
      CLINICAL-TRIAL RESULTS WITH A NEW PLASMINOGEN-ACTIVATOR

      European heart journal
    16. HAMPTON JR
      THE CONCEPT OF EQUIVALENCE AND ITS APPLICATION TO THE ASSESSMENT OF THROMBOLYTIC EFFECTS

      European heart journal
    17. HANNA GP; SMALLING RW
      RETEPLASE, A NEW 3RD-GENERATION THROMBOLYTIC AGENT

      Medicamentos de actualidad
    18. FISCHER S
      THE MOLECULAR DESIGN OF RETEPLASE

      Medicamentos de actualidad
    19. BODE C; MOSER M; RUEF J; NORDT T; PETER K; KUBLER W; SMALLING RW
      CLINICAL-STUDIES WITH RETEPLASE

      Medicamentos de actualidad
    20. BODE C; GULBA D; HUBER K; RUNGE MS
      NEW APPROACHES IN PLASMINOGEN-ACTIVATOR THERAPY

      Annals of hematology
    21. NOBLE S; MCTAVISH D
      RETEPLASE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN THE MANAGEMENT OF ACUTE MYOCARDIAL-INFARCTION

      Drugs
    22. MARTIN U; DORGE L; FISCHER S
      COMPARISON OF DESULFATOHIRUDIN (REVASC) AND HEPARIN AS ADJUNCTS TO THROMBOLYTIC THERAPY WITH RETEPLASE IN A CANINE MODEL OF CORONARY-THROMBOSIS

      British Journal of Pharmacology
    23. SMALLING RW
      MOLECULAR-BIOLOGY OF PLASMINOGEN ACTIVATORS - WHAT ARE THE CLINICAL IMPLICATIONS OF DRUG DESIGN

      The American journal of cardiology
    24. BODE C; NORDT TK; PETER K; SMALLING RW; RUNGE MS; KUBLER W
      PATENCY TRIALS WITH RETEPLASE (R-PA) - WHAT DO THEY TELL US

      The American journal of cardiology
    25. BODE C; KOHLER B; SMALLING RW; RUNGE MS
      RETEPLASE (R-PA) - A NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR

      Fibrinolysis
    26. RIJKEN DC; GROENEVELD E; BARRETTBERGSHOEFF MM
      IN-VITRO STABILITY OF A TISSUE-TYPE PLASMINOGEN-ACTIVATOR MUTANT, BM-06.022, IN HUMAN PLASMA

      Thrombosis and haemostasis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/21 alle ore 05:04:14